申请人:SMITH ROBIN ANDREW JAMES
公开号:WO2010110684A1
公开(公告)日:2010-09-30
The invention relates to triphenylphosphonium thionitrite compounds that selectively deliver nitric oxide (NO) to the mitochondria. The compounds of the invention comprise a lipophilic triphenylphosphonium cation linked to a thionitrite moiety via a linker group and a pharmaceutically acceptable anion. The compounds are useful in the treatment of diseases affected by indication of NO activity such as cancers, heart conditions, cognitive disorders and stroke.
本发明涉及三苯基膦硫亚硝酸盐化合物,可选择性地将一氧化氮(NO)传递到线粒体。该发明的化合物包括一个亲脂性的三苯基膦阳离子,通过一个连接基与硫亚硝酸盐基团和一种药学上可接受的阴离子相连。这些化合物可用于治疗受NO活性影响的疾病,例如癌症、心脏病、认知障碍和中风。